NM_001164507.2(NEB):c.21402C>T (p.Gly7134=) AND Nemaline myopathy 2
- Germline classification:
- Benign (2 submissions)
- Last evaluated:
- Dec 16, 2023
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV001056461.6
Allele description [Variation Report for NM_001164507.2(NEB):c.21402C>T (p.Gly7134=)]
NM_001164507.2(NEB):c.21402C>T (p.Gly7134=)
Condition(s)
Assertion and evidence details
Last Updated: Sep 29, 2024